Drugs / ACH-000029
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05363839 | May → Nov 2022 | — | Syneos Health | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACH-000029 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05363839 ↗ |
| Route | Oral | “administered orally via a capsule.” NCT05363839 ↗ |